BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23479569)

  • 1. Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
    Askmyr M; Ågerstam H; Hansen N; Gordon S; Arvanitakis A; Rissler M; Juliusson G; Richter J; Järås M; Fioretos T
    Blood; 2013 May; 121(18):3709-13. PubMed ID: 23479569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
    Ågerstam H; Karlsson C; Hansen N; Sandén C; Askmyr M; von Palffy S; Högberg C; Rissler M; Wunderlich M; Juliusson G; Richter J; Sjöström K; Bhatia R; Mulloy JC; Järås M; Fioretos T
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10786-91. PubMed ID: 26261316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
    Järås M; Johnels P; Hansen N; Agerstam H; Tsapogas P; Rissler M; Lassen C; Olofsson T; Bjerrum OW; Richter J; Fioretos T
    Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16280-5. PubMed ID: 20805474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.
    Warda W; Larosa F; Neto Da Rocha M; Trad R; Deconinck E; Fajloun Z; Faure C; Caillot D; Moldovan M; Valmary-Degano S; Biichle S; Daguindau E; Garnache-Ottou F; Tabruyn S; Adotevi O; Deschamps M; Ferrand C
    Cancer Res; 2019 Feb; 79(3):663-675. PubMed ID: 30514753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models.
    Ågerstam H; Hansen N; von Palffy S; Sandén C; Reckzeh K; Karlsson C; Lilljebjörn H; Landberg N; Askmyr M; Högberg C; Rissler M; Porkka K; Wadenvik H; Mustjoki S; Richter J; Järås M; Fioretos T
    Blood; 2016 Dec; 128(23):2683-2693. PubMed ID: 27621309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of hybridoma cells with IL1RAP as a new marker for leukemia stem cells and detection of its monoclonal antibody].
    Zhao K; Yin LL; Zhao DM; Wu QY; Chen C; Pan B; Zeng LY; Yao Y; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1390-3. PubMed ID: 24370017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL1RAP potentiates multiple oncogenic signaling pathways in AML.
    Mitchell K; Barreyro L; Todorova TI; Taylor SJ; Antony-Debré I; Narayanagari SR; Carvajal LA; Leite J; Piperdi Z; Pendurti G; Mantzaris I; Paietta E; Verma A; Gritsman K; Steidl U
    J Exp Med; 2018 Jun; 215(6):1709-1727. PubMed ID: 29773641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.
    Barreyro L; Will B; Bartholdy B; Zhou L; Todorova TI; Stanley RF; Ben-Neriah S; Montagna C; Parekh S; Pellagatti A; Boultwood J; Paietta E; Ketterling RP; Cripe L; Fernandez HF; Greenberg PL; Tallman MS; Steidl C; Mitsiades CS; Verma A; Steidl U
    Blood; 2012 Aug; 120(6):1290-8. PubMed ID: 22723552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD45
    Heo SK; Noh EK; Ju LJ; Sung JY; Jeong YK; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
    BMC Cancer; 2020 Apr; 20(1):285. PubMed ID: 32252668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis.
    De Boer B; Sheveleva S; Apelt K; Vellenga E; Mulder AB; Huls G; Jacob Schuringa J
    Haematologica; 2021 Dec; 106(12):3067-3078. PubMed ID: 33121233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
    Fields JK; Kihn K; Birkedal GS; Klontz EH; Sjöström K; Günther S; Beadenkopf R; Forsberg G; Liberg D; Snyder GA; Deredge D; Sundberg EJ
    Front Immunol; 2021; 12():779100. PubMed ID: 35003094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and Assessment of IL1RAP Monoclonal Antibody].
    Yin LL; Ruan SH; Tian Y; Xu KL; Zhao K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):962-5. PubMed ID: 26314426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live kinase B1 maintains CD34
    Wang H; Wang X; Xin N; Qi L; Liao A; Yang W; Liu Z; Zhao C
    Mol Cell Biochem; 2017 Oct; 434(1-2):25-32. PubMed ID: 28397012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo.
    Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A
    Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.
    She M; Niu X; Chen X; Li J; Zhou M; He Y; Le Y; Guo K
    Cancer Lett; 2012 May; 318(2):173-9. PubMed ID: 22198207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.
    Jin L; Lee EM; Ramshaw HS; Busfield SJ; Peoppl AG; Wilkinson L; Guthridge MA; Thomas D; Barry EF; Boyd A; Gearing DP; Vairo G; Lopez AF; Dick JE; Lock RB
    Cell Stem Cell; 2009 Jul; 5(1):31-42. PubMed ID: 19570512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Hsp32 inhibitors SMA-ZnPP and PEG-ZnPP exert major growth-inhibitory effects on D34+/CD38+ and CD34+/CD38- AML progenitor cells.
    Herrmann H; Kneidinger M; Cerny-Reiterer S; Rülicke T; Willmann M; Gleixner KV; Blatt K; Hörmann G; Peter B; Samorapoompichit P; Pickl W; Bharate GY; Mayerhofer M; Sperr WR; Maeda H; Valent P
    Curr Cancer Drug Targets; 2012 Jan; 12(1):51-63. PubMed ID: 22165967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
    Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ
    Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].
    Wu HH; Cao H; Wang YZ; Wang DX; Lin HR; Qin YZ; Chang Y; Hao L; Li LD; Li JL; Ruan GR; Huang XJ; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.